July 02, 2025

UK Plans Nationwide DNA Sequencing of Newborns

The scheme aims to prevent disease, but some experts are skeptical

The Analytical Scientist

June 27, 2025

Weight Loss Drugs, Heavier Implications

New guidance positions GLP-1 and GLP-1/GIP therapies as frontline options for long-term weight management—with profound implications for cardiovascular outcomes, access equity, and chronic disease care.

Conexiant

January 23, 2024

Metagenomic Next-Generation Sequencing in Osteoarticular Infections With a Focus on Pediatrics: Current Concepts and Clinical Applications

Osteoarticular infections (OAI) are a significant cause of morbidity and mortality. Cultures and serology are some of the gold standards for identifying infection but are often unable to provide a timely diagnosis or a diagnosis at all.

Phoenix Children's Medical Connection

October 31, 2024

First-in-Class Therapy for Ulcerative Colitis Proves Effective in Clinical Trial

Tulisokibart, a monoclonal antibody designed specifically to bind to TL1A, a protein involved in the inflammatory process of ulcerative colitis, proved safe and effective in a phase 2 trial involving patients who had failed other therapies. It is the first drug in its class and would provide a novel treatment pathway for these patients.

Mount Sinai New York

July 18, 2023

Mount Sinai Helps Set the Standards For Hep B Screening and Vaccination Worldwide

Mount Sinai Health System is leading the fight against hepatitis B, having launched a universal screening and vaccination campaign across New York City in the fall of 2022, while heading up the development of a bold new set of guidelines to streamline testing, diagnosis, and management of the disease.

Mount Sinai New York

July 18, 2023

Liquid Biopsy “Reliable and Accurate” With Early Cancer Detection

A specialized blood test can identify the presence of tumor cells in their earliest possible stage, is far less invasive than a traditional tissue biopsy, and can be used for both screening and surveillance.

Mount Sinai New York

February 18, 2025

When Back Pain Could Indicate a Serious Infection

Low back pain is the leading cause of disability worldwide, according to the World Health Organization.

Baptist Health South Florida

February 27, 2024

Long-Term Data from Mount Sinai Reveals SARS-CoV-2 Infection and Vaccine-Induced Antibody Responses Are Long-Lasting

A long-term analysis conducted by leading microbiologists at the Icahn School of Medicine at Mount Sinai reveals that antibody responses induced by COVId-19 vaccines are long-lasting.

Mount Sinai New York

March 21, 2024

Procalcitonin Levels in Identifying Bacterial Infections in Children with and without COVID-19

Elevated procalcitonin levels have been associated with bacterial infection in children. Observational studies reported high procalcitonin values in COVID-19. Data on bacterial coinfections in pediatric COVID-19 is sparse; small studies suggest a low coinfection rate. In this study, the authors aimed to quantify the positive predictive value (PPV) of procalcitonin in identifying bacterial infection in children with and without COVID-19. 

Cedars-Sinai Pulse